CytoMed Therapeutics (GDTC) News
NASDAQ: GDTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GDTC news summary
We found 1 recent headline mentioning CytoMed Therapeutics (GDTC): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. GDTC is making an outsized move today, down 5.81% at $0.89, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency", was published by GlobeNewswire on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology